Recent Company News

• 08:09 AM ET Oct 13, 2026
  

  Street Takeaways - Givaudan Q3 sales (CHF 3792.00, +304.00)

• 06:57 AM ET Oct 13, 2026
  

  Tech, miners, luxury the big laggards; chemicals, health and insurance gain:

• 04:20 AM ET Oct 13, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (80 total)

• 03:52 AM ET Oct 13, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:44 AM ET Oct 13, 2026
  

  StreetAccount Summary - European pre-market trading update

• 02:06 AM ET Oct 13, 2026
  

  StreetAccount Metrics Recap - Givaudan Q3 Sales (CHF 3488.00, 0.00)

• 12:30 AM ET Oct 13, 2026
  

  Givaudan reports Q3 revenue CHF2.09B vs consensus CHF1.99B (CHF 3488.00, 0.00)

• 04:24 AM ET Oct 12, 2026
  

  StreetAccount Consensus Metrics Preview - Givaudan Q3 Sales (CHF 3438.00, -2.00)

• 07:44 AM ET Oct 05, 2026
  

  Health Care and Chemicals lead; Industrials and Construction & Materials the notable decliners:

• 01:10 AM ET Oct 05, 2026
  

  Givaudan upgraded to overweight from equal weight at Barclays (CHF 3360.00, 0.00)